Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis

por van Bommel, Majke H D, IntHout, Joanna, Veldmate, Guus, Kets, C Marleen, de Hullu, Joanne A, van Altena, Anne M, Harmsen, Marline G
Publicado 2022

A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing

por Harmsen, Marline G., Steenbeek, Miranda P., Hoogerbrugge, Nicoline, van Doorn, Helena C., Gaarenstroom, Katja N., Vos, M. Caroline, Massuger, Leon F.A.G., de Hullu, Joanne A., Hermens, Rosella P.M.G.
Publicado 2017

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study...

por Harmsen, Marline G., Arts-de Jong, Marieke, Hoogerbrugge, Nicoline, Maas, Angela H. E. M., Prins, Judith B., Bulten, Johan, Teerenstra, Steven, Adang, Eddy M. M., Piek, Jurgen M. J., van Doorn, Helena C, van Beurden, Marc, Mourits, Marian J. E., Zweemer, Ronald P., Gaarenstroom, Katja N., Slangen, Brigitte F. M., Vos, M. Caroline, van Lonkhuijzen, Luc R. C. W., Massuger, Leon F. A. G., Hermens, Rosella P. M. G., de Hullu, Joanne A.
Publicado 2015

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors

por van Bommel, Majke H. D., Steenbeek, Miranda P., IntHout, Joanna, Hermens, Rosella P. M. G., Hoogerbrugge, Nicoline, Harmsen, Marline G., van Doorn, Helena C., Mourits, Marian J. E., van Beurden, Marc, Zweemer, Ronald P., Gaarenstroom, Katja N., Slangen, Brigitte F. M., Brood-van Zanten, Monique M. A., Vos, M. Caroline, Piek, Jurgen M., van Lonkhuijzen, Luc R. C. W., Apperloo, Mirjam J. A., Coppus, Sjors F. P. J., Prins, Judith B., Custers, José A. E., de Hullu, Joanne A.
Publicado 2022